Trial Profile
Aspirin non-responsiveness and clopidogrel endpoint trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Dec 2016
Price :
$35
*
At a glance
- Drugs Clopidogrel (Primary) ; Aspirin
- Indications Angina pectoris; Coronary disorders; Myocardial infarction; Thrombosis
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms ASCET
- 31 Aug 2009 Results were published as an abstract in the proceedings of the ESC Congress 2009: Annual Congress of the European Society of Cardiology, 29 Aug 2009.
- 01 Jul 2008 Status changed from recruiting to active, no longer recruiting, according to clinicaltrials.gov.
- 17 Dec 2005 New trial record.